Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 301 AL 315

Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease

Butler T, Tey SR, Galvin JE, Perry G, Bowen RL, Atwood CS.

J Alzheimers Dis. 2024;101(3):705-713. doi: 10.3233/JAD-240334.

Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease

Zhao X, Hu Q, Wang X, Li C, Chen X, Zhao D, Qiu Y, Xu H, Wang J, Ren L, Zhang N, Li S, Gong P, Hou Y.

Eur J Med Chem. 2024 Dec 5;279:116810. doi: 10.1016/j.ejmech.2024.116810. Epub 2024 Sep 4.

The emerging role of exercise in Alzheimer's disease: Focus on mitochondrial function

Feng L, Li B, Yong SS, Wen X, Tian Z.

Ageing Res Rev. 2024 Nov;101:102486. doi: 10.1016/j.arr.2024.102486. Epub 2024 Sep 6.

[Anti-amyloid Antibody Drugs as Disease-Modifying Therapies for Alzheimer's Disease]

Sato K, Iwatsubo T.

Brain Nerve. 2024 Sep;76(9):991-995. doi: 10.11477/mf.1416202723.

[Novel Therapeutic Strategies for Alzheimer's Disease]

Tomita T.

Brain Nerve. 2024 Sep;76(9):1053-1058. doi: 10.11477/mf.1416202732.

Amyloid-β-targeting immunotherapies for Alzheimer's disease

Jin Y, Du Q, Song M, Kang R, Zhou J, Zhang H, Ding Y.

J Control Release. 2024 Nov;375:346-365. doi: 10.1016/j.jconrel.2024.09.012. Epub 2024 Sep 18.

Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

Dey A, Ghosh S, Rajendran RL, Bhuniya T, Das P, Bhattacharjee B, Das S, Mahajan AA, Samant A, Krishnan A, Ahn BC, Gangadaran P.

Int J Mol Sci. 2024 Sep 7;25(17):9690. doi: 10.3390/ijms25179690.

Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems

Daraban BS, Popa AS, Stan MS.

Molecules. 2024 Aug 27;29(17):4056. doi: 10.3390/molecules29174056.

Effects of a nurse-led staged integral art-based cognitive intervention for older adults on the Alzheimer's disease spectrum: A randomized controlled trial

Yan Y, Huang C, Lin R, Chen M, Wang Y, Xu Y, Chao Y, Zhang C, Sun W, Wang N, Ye Y, Lin M, Li H.

Int J Nurs Stud. 2024 Dec;160:104902. doi: 10.1016/j.ijnurstu.2024.104902. Epub 2024 Sep 7.

New insights into innate immunity in Alzheimer's disease: from APOE protective variants to therapies

Chen Y, Holtzman DM.

Trends Immunol. 2024 Oct;45(10):768-782. doi: 10.1016/j.it.2024.08.001. Epub 2024 Sep 14.

Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist

Kaur G, Dar ZA, Bajpai A, Singh R, Bansal R.

Clin Ther. 2024 Nov;46(11):e21-e28. doi: 10.1016/j.clinthera.2024.08.013. Epub 2024 Sep 16.

Navigating the roads ahead for Alzheimer's disease

Stirrups R.

Lancet Neurol. 2024 Oct;23(10):971. doi: 10.1016/S1474-4422(24)00374-0.

Current pharmacophore based approaches for the development of new anti-Alzheimer's agents

Sharma P, Sharma S, Yadav Y, Shukla P, Sagar R.

Bioorg Med Chem. 2024 Nov 1;113:117926. doi: 10.1016/j.bmc.2024.117926. Epub 2024 Sep 13.

Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis

Deng X, Li D.

Medicine (Baltimore). 2024 Sep 20;103(38):e39753. doi: 10.1097/MD.0000000000039753.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias